Study of Ropivacaine, a local anaesthetic drug, to assess pain after tonsillectomy.
Phase 3
- Conditions
- Health Condition 1: J350- Chronic tonsillitis and adenoiditis
- Registration Number
- CTRI/2021/08/035851
- Lead Sponsor
- Dr Aastha Bhatnagar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
with or without adenoids.
Patients with chronic tonsillitis with last episode of tonsillitis occurring 3 weeks prior to procedure.
ASA grade 1 or 2
Exclusion Criteria
Patients with acute attack of tonsillitis, peritonsillar abscess, bleeding disorder and anaemia.
Patients undergoing other ENT procedures like myringotomy
Patients hypersensitive to Ropivacaine
Patients below the age of 5 years and above the age of 50 years
ASA grade 3 or more
Patients not willing for surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of pre-incisional infiltration of Ropivacaine for post tonsillectomy pain relief.Timepoint: 0 hours, 4 hours and 8 hours after surgery.
- Secondary Outcome Measures
Name Time Method To study the effect of pre-incisional infiltration of Ropivacaine for post tonsillectomy pain relief.Timepoint: 24 hours and 48 hours after surgery